NM_001308210.2:c.503C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001308210.2(TSHZ1):​c.503C>T​(p.Thr168Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00228 in 1,519,166 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 11 hom., cov: 23)
Exomes 𝑓: 0.0017 ( 15 hom. )

Consequence

TSHZ1
NM_001308210.2 missense

Scores

18

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.06

Publications

4 publications found
Variant links:
Genes affected
TSHZ1 (HGNC:10669): (teashirt zinc finger homeobox 1) This gene encodes a colon cancer antigen that was defined by serological analysis of recombinant cDNA expression libraries. The encoded protein is a member of the teashirt C2H2-type zinc-finger protein family and may be involved in transcriptional regulation of developmental processes. Mutations in this gene may be associated with congenital aural atresia syndrome. [provided by RefSeq, Jan 2012]
TSHZ1 Gene-Disease associations (from GenCC):
  • aural atresia, congenital
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • congenital vertical talus
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029379427).
BP6
Variant 18-75285910-C-T is Benign according to our data. Variant chr18-75285910-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 327802.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00769 (1117/145244) while in subpopulation AFR AF = 0.0238 (927/39004). AF 95% confidence interval is 0.0225. There are 11 homozygotes in GnomAd4. There are 534 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 1117 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSHZ1NM_001308210.2 linkc.503C>T p.Thr168Ile missense_variant Exon 2 of 2 ENST00000580243.3 NP_001295139.1 Q6ZSZ6-1
TSHZ1NM_005786.6 linkc.368C>T p.Thr123Ile missense_variant Exon 2 of 2 NP_005777.3 Q6ZSZ6-2A7YF73

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSHZ1ENST00000580243.3 linkc.503C>T p.Thr168Ile missense_variant Exon 2 of 2 2 NM_001308210.2 ENSP00000464391.1 Q6ZSZ6-1

Frequencies

GnomAD3 genomes
AF:
0.00768
AC:
1115
AN:
145134
Hom.:
11
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0238
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00558
Gnomad ASJ
AF:
0.00504
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000452
Gnomad FIN
AF:
0.000200
Gnomad MID
AF:
0.0129
Gnomad NFE
AF:
0.00104
Gnomad OTH
AF:
0.00866
GnomAD2 exomes
AF:
0.00313
AC:
469
AN:
150066
AF XY:
0.00266
show subpopulations
Gnomad AFR exome
AF:
0.0277
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.00363
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.00577
GnomAD4 exome
AF:
0.00171
AC:
2350
AN:
1373922
Hom.:
15
Cov.:
32
AF XY:
0.00161
AC XY:
1091
AN XY:
677780
show subpopulations
African (AFR)
AF:
0.0257
AC:
802
AN:
31232
American (AMR)
AF:
0.00404
AC:
144
AN:
35656
Ashkenazi Jewish (ASJ)
AF:
0.00428
AC:
106
AN:
24788
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35358
South Asian (SAS)
AF:
0.000700
AC:
55
AN:
78536
European-Finnish (FIN)
AF:
0.0000216
AC:
1
AN:
46218
Middle Eastern (MID)
AF:
0.0113
AC:
57
AN:
5060
European-Non Finnish (NFE)
AF:
0.000884
AC:
937
AN:
1060150
Other (OTH)
AF:
0.00436
AC:
248
AN:
56924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
135
270
406
541
676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00769
AC:
1117
AN:
145244
Hom.:
11
Cov.:
23
AF XY:
0.00756
AC XY:
534
AN XY:
70612
show subpopulations
African (AFR)
AF:
0.0238
AC:
927
AN:
39004
American (AMR)
AF:
0.00557
AC:
80
AN:
14350
Ashkenazi Jewish (ASJ)
AF:
0.00504
AC:
17
AN:
3372
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4904
South Asian (SAS)
AF:
0.000452
AC:
2
AN:
4428
European-Finnish (FIN)
AF:
0.000200
AC:
2
AN:
9978
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
290
European-Non Finnish (NFE)
AF:
0.00104
AC:
69
AN:
66034
Other (OTH)
AF:
0.00858
AC:
17
AN:
1982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00400
Hom.:
3
Bravo
AF:
0.00936
ESP6500AA
AF:
0.0211
AC:
90
ESP6500EA
AF:
0.000478
AC:
4
ExAC
AF:
0.00181
AC:
200

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 22, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TSHZ1-related disorder Benign:1
Jul 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
13
DANN
Benign
0.62
DEOGEN2
Benign
0.13
.;T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.37
T;T;T
MetaRNN
Benign
0.0029
T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
1.4
.;L;.
PhyloP100
2.1
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.0
N;.;.
REVEL
Benign
0.12
Sift
Benign
0.032
D;.;.
Sift4G
Benign
0.10
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.079
MVP
0.33
MPC
0.41
ClinPred
0.0075
T
GERP RS
4.2
Varity_R
0.048
gMVP
0.44
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112669427; hg19: chr18-72997865; COSMIC: COSV59011545; COSMIC: COSV59011545; API